TREATMENT OF GRAFT-VERSUS-HOST DISEASE

摘要

This present application describes a therapeutic agent for treating acute or chronic graft-versus-host disease using clonal marrow stem cells (cMSCs) as active ingredient.

主权项

1. A method of inhibiting activity of T-cell from donor marrow in a subject identified as suffering from graft-versus-host disease, comprising administering to the subject in need thereof a therapeutically effective amount of a population of homogeneous clonal marrow stem cells.